Inhibiting the activation of Met in CD44v6+ HCC cells in vivo and in vitro using specific inhibitors and lentiviruses led to a significant decrease in expression of the downstream transcription factor, cJun, and the stemness-associated gene, Nanog. Here, MET is linked to hepatocellular carcinoma.